期刊
BRAIN
卷 143, 期 8, 页码 2576-2593出版社
OXFORD UNIV PRESS
DOI: 10.1093/brain/awaa179
关键词
glymphatic; tau; aquaporin-4; Alzheimer's disease; rTg4510
资金
- Eli Lilly and Company
- Engineering and Physical Sciences Research Council (EPSRC) UK [EP/N034864/1]
- Alzheimer's Research UK [ARUK-RF2019A-003]
- Parkinson's UK [F-1902]
- Wellcome Trust/Royal Society Sir Henry Dale Fellowship [204624/Z/16/Z]
- EPSRC [EP/N034864/1]
- King's College London
- UCL Comprehensive Cancer Imaging Centre CR-UK EPSRC
- MRC
- DoH (England)
- UK Regenerative Medicine Platform Safety Hub [MRC: MR/K026739/1]
- Wellcome Trust [204624/Z/16/Z] Funding Source: Wellcome Trust
Harrison et al. show that regional variation in glymphatic function dictates tau accumulation in a mouse model of Alzheimer's disease tauopathy. Modifying glymphatic flow by pharmacologically targeting aquaporin-4 alters tau clearance, suggesting therapeutic potential against tauopathies. The glymphatic system, that is aquaporin 4 (AQP4) facilitated exchange of CSF with interstitial fluid (ISF), may provide a clearance pathway for protein species such as amyloid-beta and tau, which accumulate in the brain in Alzheimer's disease. Further, tau protein transference via the extracellular space, the compartment that is cleared by the glymphatic pathway, allows for its neuron-to-neuron propagation, and the regional progression of tauopathy in the disorder. The glymphatic system therefore represents an exciting new target for Alzheimer's disease. Here we aim to understand the involvement of glymphatic CSF-ISF exchange in tau pathology. First, we demonstrate impaired CSF-ISF exchange and AQP4 polarization in a mouse model of tauopathy, suggesting that this clearance pathway may have the potential to exacerbate or even induce pathogenic accumulation of tau. Subsequently, we establish the central role of AQP4 in the glymphatic clearance of tau from the brain; showing marked impaired glymphatic CSF-ISF exchange and tau protein clearance using the novel AQP4 inhibitor, TGN-020. As such, we show that this system presents as a novel druggable target for the treatment of Alzheimer's disease, and possibly other neurodegenerative diseases alike.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据